Loading...
[YZi Labs Condemns CEA Industries' Poison Pill Plan and Deprivation of Shareholder Rights] YZi Labs reviewed CEA Industries' response to its written consent solicitation process, accusing the board of obstructing shareholder rights through the adoption of a poison pill plan and amendments to the company bylaws, as well as delaying the 2025 annual meeting until after the December 17 anniversary date. YZi Labs refuted CEA Industries' statement regarding the lack of consideration for alternative token strategies, pointing out that CEO David Namdar had mentioned a shift toward assets like Solana at an industry conference in November 2025. YZi Labs urges the board to ensure a fair process for director nominations and elections.